Published human clinical study supports athletes’ anecdotal feedback and observations from previous studies
There’s long been something intriguing about TSI Group’s sport nutrition ingredient, PEAK ATP that warranted further investigation. There is substantial anecdotal evidence that it improves post-exercise mental clarity, focus and reaction times. Now a human clinical study published in Frontiers in Nutrition substantiates these incredibly important benefits.
PEAK ATP is a clinically validated and patented form of Adenosine 5’-Triphosphate (ATP) Disodium that’s identical in structure to the ATP produced and used by the human body. It provides functional energy, particularly in combination with exercise, enabling users to do more and achieve more, with less fatigue.
“We’ve always understood how PEAK ATP works as a pre workout supplement. But we’ve also heard from athletes and previous study participants that they feel better and have less brain fog, post exercise with this ingredient,” says TSI Group President Larry Kolb. “That’s why this study came to life. We wanted to see if there was something measurable going on.”
Kolb confirms these post-workout benefits are in high demand. “Professional athletes understand the importance of not having their reaction time decline at crucial times. Improved cognitive benefits and reaction times, after participating in a high-intensity activity for a while, are good for team athletes as well as golfers, tennis players and anyone else who needs to maintain their focus throughout a match or game.”
Study design and details
Bouts of high intensity sprint exercise (HISE) are common in many sports. They’ve been shown to elicit fatigue-associated lapses in concentration, decision making and skill performance.
For this placebo-controlled crossover study, University of Central Florida researchers recruited 20 men and women in their 20s. Because the study involved proactive and reactive response time testing with a visual system consisting of a 4 ft x 4 ft computer integrated board called Dynavision, participants were familiarized with the testing equipment ahead of time, to ensure there was no learning curve.
After familiarization, subjects were randomly assigned to either the placebo or 400 mg PEAK ATP groups, with supplementation lasting 14 days. Then, they returned to the lab for testing. Thirty minutes after consuming a dose of their assigned supplement, they completed another series of response-time tests and the cognitive questionnaires. This was followed by an exercise warm-up period and three minutes of high-intensity cycling. The tests and questionnaires were repeated immediately post-exercise and again 60 minutes later. After a 14-day washout period, subjects repeated the process with the alternative supplement.
Observes TSI Group Director of Clinical Research John A. Rathmacher, Ph.D., “When compared with the placebo, PEAK ATP prevented the decline in proactive reaction times both immediately post exercise and at 60 minutes post exercise. As important, PEAK ATP supplementation decreased the number of errors made during a reactive visuomotor task before and after high-intensity exercise. These data suggest that Peak ATP may mitigate exercise induced cognitive dysfunction following high intensity exercise. Preventing cognitive dysfunction after exercise would be very important for athletes”
Confirms Kolb, “These results add an extra layer of benefits to taking PEAK ATP before exercise. Now that we have science-backed data confirming its post-exercise benefits regarding reaction time and improved accuracy, PEAK ATP is entering the nootropic space within sports nutrition, offering both physical and cognitive benefits.
“This is significant for more than professional or elite athletes. For example, these post-exercise benefits also add value to anyone who works out early in the morning and doesn’t want to arrive at the office suffering from brain fog.
“Overall, this research has strong implications for sports nutrition products that want to distinguish themselves from the competition.
For additional information, visit www.peakatp.com.